Print Friendly

Business Operations Committee

The Business Operations Committee focuses on streamlining day-to-day pathology processes and practices for greater efficiency and effectiveness, such as data workflow, software enhancements, error checking, and rejection practices. It also identifies opportunities that support improved cancer incidence reporting. The committee conducts its work by:

  • Gauging how the processes are currently completed
  • Understanding how others do it (both inside and outside the industry)
  • Evaluating opportunities for change, including better use of information technology
  • Eliminating non-value-added work to reduce labor and accelerate processes


The committee offers recommendations on improvements to workflow practices in order to meet the needs of pathologists and other business interests. It works in a complementary manner with the College of American Pathologists (CAP) pathology electronic reporting task team (PERT).

It also works in conjunction with both the Data Analytics and Research Development Committee and the Standards and Technology Committee to make recommendations on the development of metrics, reports, software enhancements, and analytics needed to support operational enhancements, process improvements, quality measures, and general data usefulness.

  • Chairperson: Sandra Slater, St. Joseph Health
  • Sub-Chairperson: John Murphy, mTuitive
  • Sub-Chairperson: Member from the College of American Pathologists: Pathology Electronic Reporting Task Force (CAP PERT)

Data Analytics and Research Development Committee

The Data Analytics and Research Development Committee has two main areas of responsibility: to identify and pursue areas of research development, and to develop analytic capabilities that support of research development, new toolkits, protocols, decision-support capabilities, operational improvements, quality measures, and other areas that broadly align with consortium goals and objectives.


The committee collaborates with healthcare technology stakeholders, cancer researchers, cancer epidemiologists, county health officers, hospital administrators and public health organizations to identify areas of possible research priorities; and to develop new toolkits, protocols, decision-support capabilities, innovative analytics, and strategic initiatives.

It also provides leadership and support for the development of new products and procedures, as well as for the improvement of those that already exist; develops new products and processes to improve and expand pathology operations; and draws on existing knowledge gained from research and/or experience that is then directed to develop new processes, systems, and services, or to substantially improve those that already exist.

The data analytics component of this committee has two streams of work, focusing on: identifying and filling key data gaps, and supporting analytic capacity within the consortium. The objectives of this initiative include:

  • Enhancing and creating capacity to support the analysis and use of evidence-based data
  • Enabling reporting related to cancer pathology diagnoses in a consistent manner, so that the data can be used to achieve the goals and objectives of CDMC’s stakeholders

The research development component of this committee collaborates with healthcare technology stakeholders, cancer researchers, cancer epidemiologists, county health officers, hospital administrators, and public health organizations to identify possible research priorities, with the aim of developing competitive grant proposals. The process for achieving this aim includes:

  • Identifying the sources of data
  • Generating the idea – scoping the research question and conducting literature reviews
  • Refining the research questions
  • Specifying goals, hypotheses, objectives, and outcome measures
  • Creating the research design
  • Writing the proposal

The two realms of work within the Data Analytics and Research Development Committee are closely intertwined, and together will accelerate the uptake and translation of the best evidence and knowledge into practice, research, and policy.

  • Chairperson: Jeremy Pine, California Cancer Registry, California Department of Public Health
  • Sub-Chairperson: Dan Desmond, Simi Group

Standards and Technology Committee

The Standards and Technology Committee plays two important roles. The first is to leverage California Cancer Registry (CCR) control of data standards for cancer reporting within California, in combination with CAP’s influence on pathology reporting, in order to develop standards that can be implemented by internal and external stakeholders in support of CDMC’s goals and objectives, including:

  • Real-time reporting of cancer
  • Improved pathology reporting
  • Data interoperability
  • New research
  • Electronic exchange of health information
  • Development of decision-support systems
  • Data aggregation and analytics
  • Operational improvements


In general, the recommends suggests new standards and specifications that can be implemented by other stakeholders and external industry partners. It develops standards and technological solutions that ultimately can be applied and utilized at the national level.

The committee works in conjunction with other consortium committees to support the development of standards that serve and support other committees’ endeavors.

The second role of this committee is to provide oversight on matters of information technology and to set the CDMC’s information-technology strategic direction.

The committee stays abreast of new and emerging technologies both inside and outside the stakeholder community, reviews and recommends priorities for the development of stakeholder applications, and serves as an information-sharing forum. It also advises other committees about technology plans recommended for consideration.

  • Chairperson: Daniel Rutz, Epic
  • Sub-Chairperson: Cheryl Moody, Institute of Population Health Improvement, UC Davis Health Systems

Finance Committee

The Finance Committee has two primary responsibilities. The first is to develop a business case targeted at healthcare management that makes the case for the adoption and implementation of standardized pathology reporting of cancer data.


The business case will demonstrate to executive decision-makers the inherent value of what the consortium is proposing. Among the questions it will address are:

  • What are the compelling business drivers?
  • What benefits are expected and do they align with industry business strategies?
  • What factors are critical for a defined successful outcome?
  • Why is a particular option preferred over other alternatives?
  • How will funding be secured and will the cost be affordable?
  • When and how will the benefits be delivered?
  • What is the return on investment?
  • What are the strategies for new or improved cost recovery?
  • What are the risks and how will they be managed?

The committee’s second responsibility is to secure the funds needed to achieve the consortium’s goals and objectives, as outlined in its Charter. This goal can be accomplished by compiling a compendium of revenue-generation ideas, applying for grants, and seeking internal and external sources of funds – both traditional and non-traditional sources of funds – that support CDMC’s mission.

  • Chairperson: Debbie Hintz, California Cancer Registry, California Department of Public Health
  • Sub-Chairperson: Maya Ogden, College of American Pathologists

Outreach and Communications Committee

The Outreach and Communications Committee proposes and creates approaches that promote awareness of the work of the consortium to gain recognition and educate a broader external audience. The purpose of the committee is to disseminate information about the activities, goals, and aspirations of the consortium to the healthcare industry, potential stakeholders, internal participants and the public at large.


These efforts include issuing press releases across media platforms, as well as creating displays and exhibits, YouTube videos, social media, and other communication. The educational activities of the committee will include:

  • Designing and developing communication tools and strategies that reach a wide variety of audiences, including the general public, practitioners, community partners, agencies, software vendors, and healthcare industry management.
  • Testing developed tools for cognitive accessibility on the part of the user audience; conducting test interviews with a variety of target audiences such as those listed above
  • Utilizing web-based, print, and email communications to keep consortium members connected, involved, and up-to-date
  • Disseminating products and services from consortium stakeholders
  • Working with other CMDC committees to communicate their outputs and initiatives
  • Determining current training needs of the stakeholder community, with input from the community itself, with the aim of creating an education plan
  • Chairperson: Steve Fuchslin, California Cancer Registry, California Department of Public Health
  • Sub-Chairperson: Ted Carithers, College of American Pathologists

Policy Committee

The Policy Committee ormulates position papers on policy issues in order to:

  • Develop recommendations to the consortium about creating and adopting basic policies, such as privacy rules and stipulations, organizational rules (such as bylaws), consortium membership, and organizational forms and rules
  • Assist the consortium in analyzing how public-policy trends and legislation can impact the goals and objectives of CDMC’s stakeholders
  • Monitor the effectiveness of governance policies and recommend changes and/or new policies for consortium action
  • Revise the committee descriptions and make recommendations to the consortium for action (typically reviewed about every two years)
  • Review and recommend optimum composition of the consortium membership
  • Design and execute process to recruit and retain the best consortium members to help achieve the goals and objectives outlined in the CDMC’s charter


  • Chairperson: Bob Achermann, California Society of Pathologists
  • Sub-Chairperson: Steve Fuchslin, California Cancer Registry, California Department of Public Health